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Abstract: Small nucleolar RNAs (snoRNAs) in cooperation with their associated proteins (snoRNPs)
contribute to the maturation of ribosomal RNA, transfer RNA, and other transcripts. Most snoRNPs
mediate chemical base modifications of their RNA substrates, and a few others, like those formed by
the C/D snoRNAs U3, U8, and U13, are needed for the structural organization and maturation
of primary transcripts. The U3-, U8-, and U13snoRNAs are encoded by autonomous genes,
and our knowledge about their expression regulation is limited. In this study, a significant increase
in the concentrations of U3-, U8-, and U13snoRNA after a knockdown of DEAD box proteins
Ddx5/Ddx17 in HeLa cells is observed. These alterations are shown to be caused by transcriptional
suppression mediated by Ddx5/Ddx17 via histone deacetylase 1 in a promoter-dependent way.
The biological function of this expression control may be related to the role of Ddx5/Ddx17 in cell
proliferation. The U3snoRNA is shown here to be essential for the proliferation and viability of
human cells. Moreover, it was found that U3snoRNA interacts with Argonaute 2 in the RNA-induced
silencing complexes (RISC), pointing to a microRNA-like function. For this reason, the 3′ untranslated
region of the A-kinase anchor protein 9 (AKAP9)-mRNA could be identified as a potential target.
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1. Introduction
The small nucleolar RNAs (snoRNAs) are non-coding RNAs with a length of 60–600 nucleotides [1],
and are highly conserved within different species [2]. According to their conserved nucleotide
sequence motifs, they are split into the H (ANANNA, N = any nucleotide)/ACA box snoRNAs
and the C (UGAUGA/U)/D (CUGA) box snoRNAs [3]. snoRNAs are primarily found in the
nucleolus associated with specific proteins to form the small nucleolar ribonucleoprotein complexes
(snoRNPs) [4]. Most of them function as “guide” RNAs in the post-transcriptional modification of
primary transcripts (e.g., pre-ribosomal RNAs and pre-spliceosomal RNAs) [4]. Some others, like the
C/D snoRNAs U3, U8, and U13, ensure correct rRNA folding and hence cleavage by base pairing
with their substrates [5,6]. The U3- and U13snoRNAs are involved in the maturation processes
of the 18S rRNA [7,8], and U8snoRNA is involved in the maturation process of the 28S and 5.8S
rRNA [6]. In addition, certain snoRNAs are essential for growth in the yeast Saccharomyces cerevisiae [1].
Some others are involved in the mediation of metabolic stress [9], the regulation of alternative
splicing [10], or the negative regulation of gene expression [11,12]. In contrast to most snoRNA genes
found within introns of host genes [13,14], those of U3-, U8-, and U13snoRNAs are self-developed and
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have their own promoters for independent transcription [15]. The knowledge about their expression
regulation, however, is sparse.
The DEAD box proteins Ddx5 (p68) and Ddx17 (isoforms p72 and p82) modulate RNA
secondary structures and are involved in RNA metabolic processes like ribosome biosynthesis and
splicing [16–19]. They also act as transcriptional cofactors, repressing some promoters and activating
others by interaction, e.g., with the histone deacetylase 1 (HDAC1) [20] or estrogen receptor alpha,
respectively [21]. Investigating the role of Ddx5/Ddx17 in the processing of 28S rRNA, we observed
that these proteins also influence the cellular level of U8snoRNA in HeLa cells [19]. Here, the scope
of these investigations was expanded to the expression of further snoRNAs, notably those encoded
by autonomous genes. We found a distinct inhibition of U3-, U8-, and U13snoRNA transcription by
Ddx5/Ddx17. The inhibition is most probably mediated by the interactions with promoter bound
HDAC1. In addition, HeLa cell proliferation and viability are shown to be dependent on the presence of
U3snoRNA, and thus Ddx5/Ddx17 may negatively regulate these processes by their expression control.
Furthermore, we show for the first time that U3snoRNA has a microRNA (miRNA)-like function,
and the A-kinase anchor protein 9 (AKAP 9)-mRNA was identified as one of its potential targets.
2. Results
2.1. Ddx5 Regulates the Expression of U3-, U8-, and U13snoRNA
We have shown previously that the cellular concentration of U8snoRNA increases significantly
with reduced levels of Ddx5 and Ddx17 in HeLa cells [19]. Here we have investigated whether this
observation can be extended to the expression of other snoRNAs encoded by autonomous genes such
as U3- and U13snoRNA, that are involved in the processing of the 18S pre-rRNA [22]. Because Ddx5
and Ddx17 are highly related and are both active as transcriptional regulators [20], we used a small
interfering RNA (siRNA) targeting both DEAD box proteins in knockdown experiments (Figure 1c).
We observed an up-regulation of the cellular content of the U3-, U8-, and U13snoRNA upon Ddx5/17
siRNA transfection increasing with time and reaching a plateau after 40–48 h (Figure 1a). In contrast,
the expression of the U14snoRNA, which is also involved in the processing of pre-rRNA but encoded
in the intron of the ribosomal protein S13 (Rps13) and hence not transcribed independently [1],
was not affected. Off-target effects of the Ddx5/17si can be excluded by use of different siRNAs in the
analysis of U8snoRNA expression in previous studies [19]. Overexpression of Ddx5 from an exogenous
plasmid strongly repressed U3-, U8-, and U13snoRNA expression, whereas that of U14snoRNA was
not affected (Figure 1b,d).
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Figure 1. Effect of EAD box proteins Ddx5/ dx17 on the expression of 3-, 8-, 13-, and U14 s all
nucleolar R (snoR ). (a) orthern blot analysis after knockdo n of Ddx5/Ddx17. Total RNA
(5 µg each) from HeLa cells transfected ith indicated s all interfering R (siR ) for 48 h were
analyzed using digoxigenin-labeled snoRNA probes and a glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) mRNA probe, the latter serving as an endogenous loading control; (b) Northern blot analysis
after overexpression of Ddx5. HeLa cells were transfected with a Ddx5 expression plasmid (Ddx5-tag)
for 48 h, thereafter the total RNA was extracted and analyzed as in Figure 1a; (c) Demonstration of
efficient Ddx5/Ddx17 knockdown by Western blot analysis with α-tubulin as an endogenous loading
control; (d) Demonstration of ectopic Ddx5 expression (Ddx5-myc) by Western blot analysis with myc
antibodies. α-Tubulin was used as an endogenous loading control.
2.2. Promoter-Dependent Regulation of the U3-, U8-, and U13snoRNA Expression by Ddx5/Ddx17
Genomic regions whic are expected to represent the promoters f the U3-, U8-, and U13snoRNA
genes were isolated and cloned upstream of the promoter-less Photinus pyralis luciferase complementary
DNA (cDNA) in the plasmid pGL3-basic (pGL3-luc; Figure 2a). Promot r ctivity f the cloned
fragments and their possible dependence on Ddx5/Ddx17 were analyzed by respective luminescence
measurements. The reporter assay (Figur 2b) revealed that th cloned DNA fragments, like the SV40
early region, exp ess disti ct promoter activity in HeLa cells comparable in extend to that of the SV40
early region (Figure S2). In c trast to the SV40 early region, the basic promoter ac ivities of U3-, U8-,
and U13 n RNA were elevated after knockdown of D x5/Ddx17 expressi n (up to 15-fold). Similar
resul s were also obtained when the reporter ge s er expressed after i sertion into the cellular
genome using a lentivir l expression system. He e the huma ubiquitin C promoter was used as a
control, and expected, it did not respond to the reduct on f cellular Ddx5/Ddx17 concentrations
(Figure 2c).




Figure  2.  Promoter‐dependent  regulation  of  the  U3‐,  U8‐,  and  U13snoRNA  expression  by 
Ddx5/Ddx17. (a) Schematic drawing of the promoter regions (in black) used for the expression of the 
promoter‐less  firefly  luciferase  gene  (in  gray)  from  the  respective  pGL3‐luc  expression  plasmids 
(pGL3‐U3‐luc, pGL3‐U8‐luc, pGL3‐U13‐luc, pGL3‐SV40‐luc) or recombinant lentiviruses (pFUWluc, 




Figure 2. Promoter-dependent r gulation of the U3-, U8-, and U13s oRNA expression by Ddx5/Ddx17.
(a) Schematic drawing of the promoter regions (in black) used for the expression of the promot r-less
firefly luciferase gene (in gray) from the respective pGL3-luc expression plasmids (pGL3-U3-luc,
pGL3-U8-luc, pGL3-U13-luc, pGL3-SV40-luc) or recombinant lentiviruses (pFUWluc, pFUW-U3-luc,
pFUW-U8-luc). The numbers refer to the nucleotides upstream of the respective genomic transcription
start sites (±1); (b) and (c) Expression of firefly luciferase after knockdown of Ddx5/17 (Ddx5/17si)
from the pGL3-luc expression plasmids in HEK293 cells (b) or from recombinant lentiviruses in HeLa
cells (c) (mean ± standard deviation (SD); n = 3; * p value < 0.05). Control siRNA (contr.si) was used in
parallel experiments. Measured luciferase fluorescence was converted into relative promoter activity
units. The construct with the SV40 early promoter (pGL3-SV40-luc) was used as a negative control in
(b) and that with the human ubiquitin promoter (pFUWluc) in (c).
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2.3. The Role of HDAC1 in the Regulation of U3-, U8-, and U13snoRNA Transcription
Because Ddx5 and Ddx17 were previously shown to interact with HDAC1 [20], we further
analyzed a possible influence of trichostatin A (TSA), an inhibitor of HDAC class I and II enzymes,
on the U3-, U8-, and U13snoRNA promoter activity using the transient luciferase reporter assay.
We found that the transcription of U3-, U8-, and U13snoRNA was TSA dependent (Figure 3a).
Additional experiments showed that this was also true for the activity of the endogenous U3-, U8-,
and U13snoRNA gene promoters but not for that of the U14snoRNA used as a negative control
(Figure 3b). These results suggest that Ddx5 and a HDAC enzyme interact with the U3-, U8-,
and U13snoRNA promoter, which in fact was identified by a chromatin immunoprecipitation (ChIP)
assay as HDAC1 (Figure 4).
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Figure 3. Effect of trichostatin A (TSA) on the expression of U3-, U8-, and U13snoRNA in HeLa cells.
(a) TSA effect on the activity of isolated U3- and U8-gene promoters. Expression of firefly luciferase
from plasmids pGL3-SV40-luc, pGL3-U3-luc, and pGL3-U8-luc was analyzed in cells treated with
TSA (50 nM dissolved in dimethyl sulfoxide (DMSO) +TSA) or DMSO only (−TSA) in the transient
luciferase reporter assay, and is shown as relative promoter activity (mean ± SD; n = 3; * p value < 0.05);
(b) TSA effect on the expression of U3-, U8-, U13-, and U14snoRNA from endogenous genes. Total
RNA (5 µg each) isolated from cells treated with TSA (50 nM in DMSO; +TSA) or DMSO only (−TSA)
were analyzed by Northern blotting with GAPDH mRNA monitoring as a loading control.
In the ChIP assay, the binding of histone 3 (H3) to the U3-, U8-, and U13snoRNA promoter regions
served as a positive control. Unspecific chromatin-protein interactions were apparently not detected
under the assay conditions as shown by the use of an antibody directed against the large tumor antigen
of simian virus 40 (T-antigen, not present in HeLa cells). Furthermore, the missing binding of the HeLa
cell chromatin region 11:1983833–1983994 (reported to be free of Ddx5 [20]) to Ddx5 further confirmed
the specificity of the assay.
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Figure 4. Binding of Ddx5 and histone deacetylase 1 (HDAC1) to the promoters of the U3-, U8-, and
U13snoRNA genes in HeLa cells. The DNA regions analyzed by chromatin immunoprecipitation (ChIP)
are schematically shown on the left, each bound by a pair of rimers (arrows) showing the genomic
locatio of their first nucleot de. A non-bindi g region of chromosome 11 (CHR11: 1,983,833 1,983,994)
was used as a control. The a tibodies used in the ChIP-precipitation analysis re hown on the right.
As a control, a SV40 T-antigen-specific antibody (PAb101) was used (T-Ag). The immunoprecipitated
DNA was analyzed semi-quantitatively in comparison to indicated amounts of input DNA.
2.4. Influence of U3snoRNA Expression Level on Cell Proliferation
Our laboratory has shown before that co-silencing of Ddx5 and Ddx17 causes inhibition of cell
proliferation, perturbation of nucleolar structure, and cell death [19]. Our findings that the expression
of the U3-, U8-, and U13snoRNA genes is controlled by Ddx5/Ddx17 point to some regulatory
functions of these snoRNAs in cell life as well, as reported for another member of this non-coding
RNA family [23]. The biological relevance of such a regulatory role of U3-, U8-, and U13snoRNA
may become more obvious by altering their cellular levels. In fact, when the three snoRNAs were
overexpressed simultaneously, HeLa cell proliferation was completely inhibited (Figure 5a) and the
ability of the cells to form colonies was reduced by more than 50% (Figure 5b,c). Apoptosis was not
observed here, as indicated by the absence of poly(ADP-ribose) polymerase (PARP) fragmentation
(Figure 5d). In contrast, when the snoRNAs were overexpressed separately, proliferation of the cells
seemed to not be affected, as shown here for U3snoRNA by testing the ability of the cells to form
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colonies (Figure 6b,c). These results suggest that the essential function of U3snoRNA for cell viability
can only be titrated out by contemporary overexpression of all three snoRNAs, that seem to function
in a similar manner (and with similar interaction partners), explaining at the same time their concerted
expression control by Ddx5/Ddx17.
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blot analysis of poly(ADP‐ribose) polymerase  (FL‐PARP) and  its  cleavage product  (PARP 89kDa, 
known as an indicator of apoptotic cell death). α‐Tubulin served as a loading control. 
Figure 5. Inhibition of HeLa cell proliferation by external co-expression of U3-, U8-, and U13snoRNA.
(a) Cell proliferation on the dependence of U3-, U8-, and U13snoRNA overexpression. Cells were
transfected with a mixture of the U3-, U8-, and 13snoR expression plasmids (pcDNAU3,
pcDNAU8, pcDNAU13), or the e ty ector (pcDNA3.1(−)), and growth curves were established
in alf logarithmic scale (mean ± SD; n = 3; * p value < 0.05); (b) An overview of the outcome
of a colony forming assay performed with control and HeLa cells overproducing U3-, U8-,
and U13s oRNA; (c) Quan itative analys s of the colony forming ass y (mean ± SD; n = 3;
* p value < 0.05). (d) Western blot analysis of poly(ADP-ribose) polym rase (FL-PARP) and its cleavage
product (PARP 89kDa, known as an indicator of apoptotic cell de th). α-Tubulin served as a
loading control.

















Of  particular  interest  in  post‐transcriptional  gene  regulation, we  analyzed  the  U3snoRNA 
sequence with  the DIANAT‐online  tool  [24]  to  identify  targets  of  potential U3snoRNA‐derived 
miRNA within human genes. To capture potential miRNA regions in U3snoRNA, its sequence was 
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Figure 6. HeLa cell proliferation after external expression of U3snoRNA. Cells were transfected with the
U3snoRNA expression plasmid (pcDNAU3) or the empty vector (pcDNA3.1(−)), and were harvested
48 h thereafter. (a) Demonstration of U3snoRNA overexpression by reverse transcription polymerase
chain reaction (RT-PCR). GAPDH mRNA served as a loading control; (b) An overview of the outcome
of a colony forming assay performed with control cells and HeLa cells overproducing U3snoRNA;
(c) Quantitative analysis of the colony forming assay (mean ± SD; n = 3; * p value < 0.05).
On the other hand, U3snoRNA/RNP was shown to be an essential fac or for ribo ome maturation.
Moreover, the k ockout of U3snoRNA/RNP is kno to be lethal in mouse [22]. Inde d, this is also
confirmed in HeLa cells by the knockdown of U3snoRNA expression (Figure S1), which causes a
strong reduction of the ability of the cells to form colonies. However, the inhibition of cell proliferation
is mediated by a pro-apoptotic effect as illustrated by PARP cleavage. Interestingly, the U14snoRNA
knockdown, used as a control, did not cause cell apoptosis.
2.5. miRNA Function of U3snoRNA
Of particular interest in post-transcriptional gene regulation, we analyzed the U3snoRNA
sequence with the DIANAT-online tool [24] to identify targets of potential U3snoRNA-derived miRNA
within human genes. To capture potential miRNA regions in U3snoRNA, its sequence was split
into 202 segments, each 23 nucleotides in length and moving along the sequence with one-nucleotide
shift. The in silico analysis revealed several mRNAs. These mRNAs can bind to the potentially
U3snoRNA-derived miRNAs with variable affinity. The mRNA of AKAP9 is one of these mRNA
which represents a potential target with a score of 49 (Table S4). Figure 7a shows the predicted
complementary sequences of U3snoRNA and AKAP9 3′ untranslated region (UTR).










Figure 7. Expression regulation of a reporter construct containing the 3′ untranslated region (UTR)
of the A-kinase nchor protein 9 (AKAP9) mRNA by U3snoRNA an binding of U3snoRNA to
Argonaute 2 (Ago2); (a) Predicted complementary sequences of U3snoRNA and AKAP9 3′UTR;
(b) Control of the expression of enhanced green fluorescent protein (EGFP) by U3snoRNA via
the 3′UTR of AKAP9 mRNA linked to the EGFP-encoding cDNA (pCIneo-EGFP-3′-UTR-AKAP9).
The 3′UTR of smg5 mRNA linked to the EGFP-encoding cDNA (pCIneo-EGFP-3′-smg5) was used
as a control. We show the Western blot analysis of EGFP expressed from the respective constructs
on dependence of U3snoRNA overexpression (left) or knockdown of U3snoRNA (right). α-Tubulin
served as a loading control. Overexpression and knockdown of U3snoRNA is shown in figures 6a and
S1a; (c) Binding of U3snoRNA to Ago2. Human influenza hemagglutinin tagged Ago2 (HA-Ago2),
its siRNA-binding deficient mutant (HA Ago2_Y529E), or only the HA-tag (HA) were expressed from
respective plasmids for 72 h in HEK239 cells and resultant cell extracts immunoprecipitated with
anti-HA antibodies. An aliquot of the cell extracts (0.05%, before immunoprecipitation (IP)) as well
as an aliquot (10%) of the IP were analyzed by Western blotting using anti-HA antibodies (lanes 1–3).
The remaining immunoprecipitates were analyzed for co-immunoprecipitated U3- (lanes 4–6) and
U14snoRNA (lanes 7–9) by RT-PCR. An aliquot of cell extracts was co-analyzed for the snoRNAs
(0.05% input).
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For direct proof of the 3′UTR of AKAP9 mRNA as an U3snoRNA target, the 3′UTR sequence of
AKAP9 mRNA was cloned 3′ to the coding sequence of the enhanced green fluorescent protein (EGFP),
and a possible influence of the U3snoRNA on EGFP expression was investigated in HeLa cells.
The cells were transfected with pCIneo-EGFP-3′-UTR-AKAP9 for 24 h, followed by splitting of
the culture and transfection with either the U3snoRNA expression plasmid (pcDNAU3) or the
U3snoRNAsiRNA (U3si). The results show that the cellular EGFP concentration significantly
decreased after U3snoRNA overexpression (Figure 7b, left) and increased after U3snoRNA knockdown
(Figure 7b, right). The expression of pCIneo-EGFP-3′-UTR-smg5 was used here as a negative
control because the 3′UTR of smg5 was not identified as a predictive target in the in silico analysis.
The results clearly indicate that U3snoRNA can regulate the expression of AKAP9 probably at the
post-transcriptional level.
Mammalian Argonaute 2 (Ago2) specifically binds certain RNAs resulting in the assembly of
catalytically active Ago2 ribonucleoprotein complexes [25]. As an indicator of a miRNA function of
U3snoRNA, a possible interaction with Ago2 was investigated by RNA immunoprecipitation (RIP).
For this, human influenza hemagglutinin tagged Ago2 (HA-Ago2) or its mutant (HA-Ago2Y529E) was
overexpressed in HEK293 cells and immunoprecipitated from cell extract with HA-specific antibodies
(Figure 7c, lanes 1–3). Co-precipitated RNA was isolated and analyzed by reverse transcription
polymerase chain reaction (RT-PCR) for the presence of U3snoRNA sequences (Figure 7c, lanes 4–6).
The results showed that in contrast to U14snoRNA (Figure 7c, lane 8), U3snoRNA was actually bound
to Ago2 (Figure 7c, lane 5). The specificity of this interaction was verified by use of a miRNA-binding
mutant of Ago2 (Ago2Y529E) in a parallel RIP experiment (Figure 7c, lane 6). Taken together, these
results suggest that U3snoRNA fulfills a miRNA-like function to regulate the expression of AKAP9
and possibly additional genes.
3. Discussion
snoRNAs represent a class of small non-coding RNA molecules. In association with specific
proteins (snoRNPs), most of them perform chemical modifications of ribosomal, transfer, and small
nuclear RNAs [1]; a few, like C/D snoRNPs U3, U8, and U13 indispensably guide rRNA processing
by guaranteeing correct RNA folding [3,5]. Here, we have shown that Ddx5/Ddx17 control the
expression of U3-, U8-, and U13snoRNA (Figure 1a). Their expression regulation can be accomplished
at the transcriptional level without regard for host genes, because these snoRNAs are encoded by
autonomous genetic units (and not by intron sequences of “foreign” genes).
We show that Ddx5/Ddx17 suppress the transcription of the U3-, U8-, and U13snoRNA genes
under cellular conditions. Their knockdown, on the other hand, results in a significant increase of
U3-, U8-, and U13snoRNA in HeLa cells and enhanced their promoter activities in a transient reporter
assay. Both DEAD box proteins were concurrently addressed in most of the experiments performed
here due to their related activities and/or functions [19]. The extent of the involvement of isolated
Ddx17 in U3-, U8-, and U13snoRNA gene expression control has to be investigated. Ddx5 and Ddx17,
on the other hand, have no influence on the activity of the SV40-early promoter, indicating that their
regulatory functions are promoter specific. The control of the snoRNA promoter activity is also
observed after integration of the reporter gene constructs into chromosomal DNA using lentiviral
vehicles (Figure 2c). This suggests that it is not abolished by higher-order chromatin structures as
reported for other transcription control processes [26].
Using a ChIP assay, we demonstrate that the suppression of the U3-, U8-, and U13snoRNA gene
transcription is based on an interaction of Ddx5 with the local transcription machinery (Figure 4).
Wilson et al. [20] showed that Ddx5 and Ddx17 interact with HDAC1, inhibiting transcription from the
herpes virus thymidine kinase (TK) promoter in a promoter-specific manner. We have added to this the
U3-, U8-, and U13snoRNA genes. The HDAC1 is shown here to be involved in the regulation of these
snoRNA genes, though an involvement of additional HDACs cannot be excluded because TSA blocks
mammalian HDAC class I and II [27]. HDAC1 can perform histone deacetylation only in tandem
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with other factors, like Ddx5, which according to our results, seems responsible for snoRNA promoter
recruitment and activation of HDAC activity [28,29]. A promoter non-active HeLa cell chromatin
region (chromosome 11: 1983833-1983994 [20]) served as a negative control in these assays. Binding
of Ddx17 to the promoter regions of the snoRNA genes could not be traced because of the lack of
suitable antibodies.
With respect to the biological relevance, we observed that the expression of U3 from an exogenous
gene did not affect cell proliferation (Figure 6). However, overexpression of C/D snoRNAs was
shown by others to prevent their accumulation in Cajal bodies, and thus processing of pre-rRNA
impaired cell viability [30]. Interestingly, U3- and U14snoRNA are structurally and functionally highly
conserved in all eukaryotes, though their genes have evolved differently in the course of evolution.
In the yeast Saccharomyces cerevisiae, both U3- and U14snoRNA are encoded by autonomous genes,
while in humans this is the case only for U3snoRNA. Here, the U14snoRNA gene is encoded by intron
sequences of the gene for the ribosomal protein Rps13 [31]. Therefore, the expression of the U14snoRNA
is coupled to the transcription of ribosomal protein Rps13 and not affected by Ddx5/Ddx17 (Figure 1a).
In the yeast, both U3- and U14snoRNA are essential for cell proliferation [1]. In mammalian cells
we have shown that this is the case only for U3snoRNA, which is also required for cell survival
(Figure S1); an insufficiency of U14snoRNA seems to not impair cell viability.
Recently, it has been reported that some snoRNAs can be processed into smaller RNAs and bind to
Ago2 in RNA-induced silencing complexes (RISC) [11]. In fact, some structural resemblance of miRNA
precursors and snoRNAs exists [32,33], prompting us to investigate whether the snoRNAs examined
here may also have miRNA functions. In search of a possible target for a miRNA-like function of
U3snoRNA, we used the DIANA Lab program (DIANA-microT-CDS) which showed the highest target
score for the A-kinase anchor protein 9 (AKAP9) mRNA. This prompted us to analyze the influence
of U3snoRNA on the expression of AKAP9. Because of the size of the AKAP9 polypeptide, we were
unable to quantify AKAP9 by Western blot analysis for this purpose, and instead used a reporter
gene construct containing the 3′UTR of the AKAP9 mRNA following the coding sequence of EGFP.
The results imply that the expression of AKAP9 is controlled by a miRNA derived from U3snoRNA
in vivo. Overexpression of U3snoRNA, in contrast, showed no effect on the expression of the reporter
construct containing the 3′UTR of smg5 mRNA used here as a negative control. To find a further
indication of a miRNA-like U3snoRNA function, we searched for an interaction of U3snoRNA with
proteins of the RNAi machinery, like Ago2 (Figure 7c). It is known that Ago2 specifically binds not
only to mature miRNA (≈22 nt long) processed by Dicer from pre-miRNA [34], but also to miRNA
precursors and longer unstructured RNAs [35–37]. Here, we detected full length U3snoRNA molecules
in complex with Ago2, which may be processed to mature miRNA without contribution of Dicer, as
has been described before for pre-miRNA produced by Drosha [35–37]. The specificity of the Ago2
interaction with U3snoRNA was confirmed by the parallel use of an Ago2 mutant lacking miRNA
binding ability [38,39]. Furthermore, U14snoRNA did not bind to Ago2 under the same conditions
in a parallel experiment (Figure 7c). This, indeed, proposes that U3snoRNA has a miRNA function,
though knowledge of the regime of its processing to miRNA is missing, and a full length U3-associated
function in this context cannot be excluded. preU3snoRNA is transcribed with a long 3′ tail and fitted
with a 5′ monomethyl m7G cap in the nucleoplasm. In higher cells, trimethylation of the 5′ monomethyl
m7G cap as well as quality control of the 3′ tail takes place thereafter in Cajal bodies. At this point,
the mature snoRNA then binds to the box C/D core proteins fibrillarin [40,41], Nop56, Nop58, and
15.5K to form the early U3snoRNP [42], which is transported to the nucleolus to associate with U3-55K
resulting in the mature U3snoRNP. Interestingly, the precursor U3snoRNA with monomethylated
5′ cap is unable to associate with core box C/D snoRNP proteins (fibrillarin and hNop58) and was
detected not only in Cajal bodies, but also in the nucleoplasm, where Ago2 and miRNA-associated
RISC are also present [43].
The biological implication of AKAP9 regulation by U3snoRNA is still unclear, as well as the
biological function of AKAP9 [44]. However, our present study points to miRNA functions of the
U3 and possibly other C/D box snoRNAs, and gives a first impression of the great potential of these
snoRNAs to regulate cellular pathways.
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4. Materials and Methods
4.1. Plasmids
To generate the expression plasmid pCMVDdx5-myc, the coding sequence of pCMVDdx5wt [19]
was amplified by use of the primers Ddx5-fwd and Ddx5-rev and cloned into the SfiI/XhoI restriction
sites of pCMV-myc (Clontech, Heidelberg, Germany). For plasmids pGEM-U8 and pGEM-U14,
see [19]. pGEM-U3, pGEM-U13, and pGEM-GAPDH were constructed by insertion of the U3, U13, or
GAPDH cDNA in 3′ to 5′ orientation into the multiple cloning site of vector pGEM7zf(−) (Promega,
Madison, USA) using the XhoI/BamHI, XhoI/HindIII, and XhoI/BamHI restriction sites respectively.
The luciferase promoter reporter constructs pGL3-U3-luc, pGL3-U8-luc, and pGL3-U13-luc were
generated by cloning of the respective DNA upstream from the snoRNA’s coding sequence in the
pGL3-Basic vector of Luciferase Assay Systems from Promega using the XhoI/NcoI restriction sites.
pGL3-SV40-luc was generated by inserting the SV40 early region into the same plasmid using the
same restriction sites, and served as control. The expression plasmids of U3-, U8-, and U13 snoRNAs
(pcDNAU3, pcDNAU8, and pcDNAU13) were generated by inserting the cDNA of these snoRNAs into
the XhoI restriction site of pcDNA3.1(−) (Invitrogen, Carlsbad, CA, USA). pIRESneo-FLAG/HA-Ago2
was ordered from Addgene (Teddington, UK) (Plasmid #10822) for the expression of HA-tagged
Ago2 (HA-Ago2). The Ago2 mutant plasmid pIRESneo-FLAG/HA-Ago2Y529E was generated from
pIRESneo-FLAG/HA-Ago2 using the QuikChange II Site-Directed Mutagenesis Kit (Stratagene,
La Jolla, CA, USA) according to the manufacturer’s instructions and used for the expression of
the siRNA-binding deficient mutant (HA-Ago2Y592E). pCIneo-EGFP-3′-UTR-AKAP9 was constructed
by inserting the 3′UTR of the AKAP9 mRNA into the pCIneo-EGFP 3′ to the stop signal of EGFP
and upstream of the SV40 late poly(A) signal using the BspEI/NotI restriction sites [45]. For the
pCIneo-EGFP-3′-UTR-smg5 plasmid, see [45]. Sequences of the primers used are given in Table S1.
Correct structures of created DNA constructs were confirmed by DNA sequencing.
4.2. Cell Culture, Cell Transfection, and Exogenous Gene Expression
Hela cells (ATCC, CCL-2) and HEK293 cells (ATCC, CRL-1573) were obtained from the American
Type Culture Collection (ATCC). HEK293-T (ATCC, CRL-11268) were a gift from Gerald Thiel, Saarland
University, Medical Center, Homburg, Germany. The cells were cultured at 37 ◦C and 5% CO2
in Dulbecco’s modified Eagle’s medium (DMEM) with 10% fetal calf serum (FCS). Transfections
of DNA and siRNA were performed for 48–72 h using jetPEI (Peqlab, Erlangen, Germany) and
Interferin (Peqlab), respectively, according to the manufacturer’s protocol (for siRNA target sequences,
see Table S2; AllStars Negative Control siRNA from Qiagen (Hilden, Germany) was used as a
control). Cells were treated directly or 24 h after transfection with TSA (50 nM) dissolved in
dimethyl sulfoxide (DMSO) for 30 h. The EGFP-3′-UTR-reporter assay was performed by transfection
of pCIneo-EGFP-3′-UTR-AKAP9 or pCIneo-EGFP-3′-UTR-smg5 in HeLa cells for 24 h followed
by splitting of the cells and transfection with the expression plasmid of U3snoRNA (pcDNAU3),
as described previously [46].
4.3. Lentiviral Gene Transfer
To produce the transfer vectors pFUW-U3-luc and pFUW-U8-luc, the pGL3-U3-luc and
pGL3-U8-luc were digested with XhoI and NcoI and the resultant promoter fragments were cloned
into the PacI/BglII and PacI/BamHI restriction sites of the lentiviral transfer vector pFUWluc [47]
upstream of the luciferase gene. Viral particles were produced by triple transfection of HEK293-T
cells with the transfer vectors, the gag-pol-rev packaging plasmid, and the env plasmid encoding
vesicular stomatitis virus glycoprotein (kind gifts of Gerald Thiel, Saarland University, Medical Center,
Homburg, Germany), as described previously [48]. Used primer sequences are provided in Table S1.
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4.4. Reporter Assays
For transient expression, cells were transfected with pGL3-U3-luc, pGL3-U8-luc, pGL3-U13-luc,
or pGL3-SV40-luc for 24 h and were then treated with Ddx5/17siRNA for 48 h. For lentiviral reporter
gene expression, cells were infected with the viruses containing the respective reporter construct
for 24 h and then treated with the indicated siRNAs for 48 h. Extracts of cells were prepared using
reporter lysis buffer (Promega) and analyzed for luciferase activities as described by Thiel et al. [49].
In each case, luciferase activities were correlated to total protein concentrations and normalized to
control groups, whereby variations in control groups were less than 15%.
4.5. RNA Isolation
Total RNA was isolated from cells using the RNeasy Mini Kit (Qiagen) according to the
manufacturer’s protocol. DNase treated total RNA (1 µg) was transcribed into cDNA using random
hexamer primers and the Transcriptor High Fidelity cDNA Synthesis Kit (Roche, Mannheim, Germany),
and was used for investigating the knockdown and the overexpression of U3snoRNA.
4.6. Northern Blot Analysis
Negative strand full-length U3-, U8-, U13-, U14snoRNA, and GAPDH mRNA were obtained by
in vitro transcription of the corresponding plasmids (pGEM-U3, pGEM-U8, pGEM-U13, pGEM-U14,
and pGEM-GAPDH) in the presence of digoxigenin. Northern blot analyses were performed as
described elsewhere [17] and the signals detected according to the Roche DIG Northern Starter
Kit manual.
4.7. Antibodies
Mouse anti-tubulin (#05-829) was from Millipore (Darmstadt, Germany). For monoclonal mouse
antibody C10 and polyclonal rabbit anti-human Ddx17 antibody, see [17,19]. Mouse monoclonal
anti-c-myc (clone 9E10) and rat anti-HA (clone 3F10) antibodies were purchased from Roche. Mouse
anti-GFP (MAB3580) was from Upstate (New York, NY, USA). For monoclonal antibodies PAb101,
see [50]. Rabbit polyclonal anti-HDAC1 was from Santa Cruz (Heidelberg, Germany). Rabbit
monoclonal anti-histone H3 (D2B12XP, ChIP formulated) as well as anti-PARP antibodies were from
Cell Signaling Technology (Frankfurt, Germany); horseradish peroxidase-conjugated goat anti-mouse
(A4416) and goat anti-rabbit (A0545) antibodies were from Sigma (Taufkirchen, Germany).
4.8. RNA Immunoprecipitation (RIP)
All steps were performed at 4 ◦C. HEK293 cells were transfected for 72 h with
pIRESneo-FLAG/HA Ago2, pIRESneo-FLAG/HA Ago2_Y529E, or pCMV-HA (used as a negative
control), and were harvested by centrifugation in phosphate-buffered saline (PBS) and resuspended
in lysis buffer (20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)–NaOH, pH 7.5,
10 mM NaCl, 2 mM MgCl2, 1 mM ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-tetraacetic
acid (EGTA), 0.35% Nonidet P-40, and 0.2% Na-deoxycholate, pH 8.6) supplemented with
1 mM phenylmethylsulfonyl fluoride (PMSF), 2 mM NaVO3, and Complete Protease Inhibitor
ethylenediaminetetraacetic acid (EDTA)-free (Roche) in the presence of RiboLock RNase Inhibitor
(Fermentas, St. Leon-Rot, Germany) and Phosphatase Inhibitor Cocktail (Sigma). Cell lysates were
centrifuged at 14,000× g for 10 min. The supernatants, pre-cleared with protein A-sepharose beads,
were incubated with protein A-sepharose-bound anti-HA (Roche) overnight. RNA was purified from
the eluent by proteinase K digestion, phenol–chloroform-RNA extraction, and ethanol precipitation.
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4.9. Chromatin Immunoprecipitation (ChIP)
The cell chromatin was extracted and aliquots (10 µg) were immunoprecipitated with respective
antibodies (10 µg) by using the SimpleChIP Enzymatic Chromatin IP Kit (Cell Signaling Technology),
according to the manufacturer’s instructions. Recovered DNA was analyzed by semi-quantitative
PCR with primers specific for the indicated promoter regions. The sequences of used primers are
provided in Table S3. DNA amplification was performed with the Kappa Robust PCR Kit according to
the manufacturer’s protocol (Roche) and as described previously [19]. PCR products were analyzed
by 1.2% agarose gel electrophoresis and ethidium bromide staining.
4.10. Cell Viability and Proliferation
Cell viability was determined 24 h and 48 h after co-transfection of respective plasmids using the
trypan blue technique. For colony formation assays, 5 × 103 cells were plated in 10-cm dishes the day
after transfection, and 7–14 days thereon resulting colonies were fixed with 5% glutaraldehyde and
stained with 1% crystal violet in PBS. Growth kinetics were determined in triplicates after transfection
of respective plasmids, and cells were counted in duplicates. The resulting mean values are given.
Supplementary Materials: The following are available online at www.mdpi.com/2311-553X/2/4/11/s1,
Table S1: Primers used for construction of plasmids; Table S2: Used small interfering RNAs (siRNAs);
Table S3: Primers used for chromatin immunoprecipitation (ChIP); Table S4: Putative targets of U3snoRNA
segments functioning as microRNA (miRNA); Figure S1: Indication of apoptosis by U3snoRNA knockdown;
Figure S2: Promoter activity of the isolated U3-, U8-, and U13snoRNA gene promoters in comparison to that
of the SV40 early region. The original images for all the gels presented in this work can be found in a separate
supplementary PDF file at www.mdpi.com/2311-553X/2/4/11/s2.
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